Whereas previous studies have primarily examined genetic ablation in chronic or regenerative contexts, this work focuses on the early endotoxemic phase, providing the first pharmacologic evaluation of how concurrent ADAM10/17 inhibition influences oxidative and ER stress signaling in SA-ALI. This evidence concerns the gene ADAM10 and acute respiratory distress syndrome.